Adam J. Waxman, MD, MS, assistant professor of clinical medicine, Penn Medicine, University of Pennsylvania, discusses the future of treatment in patients with multiple myeloma.
Adam J. Waxman, MD, MS
Advertisement
Articles by Adam J. Waxman, MD, MS
Adam J. Waxman, MD, MS, discusses the STORM trial and using selinexor to treat patients with multiple myeloma.
Adam J. Waxman, MD, MS, discusses the role of transplant in patients with multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Waxman on the Role of Transplant in Multiple MyelomaPublished: October 14th 2019 | Updated:
Dr. Waxman on Selinexor in Multiple Myeloma TreatmentPublished: October 25th 2019 | Updated:
Dr. Waxman on the Future of Treatment in Multiple MyelomaPublished: November 7th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
4
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
5